Intraabdominal sequestration of the lung and elevated serum levels of CA 19-9: a diagnostic pitfall Source: Eur Respir J 2004; 24: Suppl. 48, 533s Year: 2004
Diagnostic value of CYFRA 21-1, CEA, CA19-9, CA 15-3, and CA 125 assay in pleural effusions: analysis of 116 cases and review of the literature Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005
Tumor markers (TM) CEA, MCA and CA 19-9 in pleural effusion (PE) at malignant mezothelioma and methastatic tumour of pleura Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003
Comparative evaluation of CA-125, CA 19-9, CA 15-3 and CEA in exudative benign and malignant pleural effusion Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010
The effect of smoking on blood and lavage fluid IL-4, 6, 10, 12, 13, TNF-α and γ-INF levels of rats with bleomycin induced pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007
Clinical evaluation of NSE, CYFRA 21-1, CEA and MCA at patients (pts.) with metastatic pleural effusion (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005
Biodynamic approach to pretreatment level of tumor marker CYFRA 21-1 in differential diagnosis of single pulmonary nodules Source: Annual Congress 2003 - Early lung cancer diagnosis Year: 2003
Expression of claudins 1, 2, 3, 4, 5 and 7 in usual interstitial pneumonia and sarcoidosis Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease Year: 2007
Role of the specific airway resistance (sRaw) in 4-6 years fibrosis cistic patients Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004
Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE) Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001
Nasal NO reference values in 6-17 year-old children Source: Eur Respir J 2004; 24: Suppl. 48, 270s Year: 2004
Serum CA 19-9 in lung allograft recpients Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006
Upper respiratory symptoms in children (3-12 years old) exposed on different levels of ambient particulate matter. Source: Virtual Congress 2020 – Air pollution as a cause of respiratory disease Year: 2020
A dose ranging study of the aeris polymeric lung volume reduction (PLVR) system in patients with advanced upper lobe predominant (ULP) emphysema Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009
38 kDa/CFP-10 associated to 16 kDa recognised by asymptomatic contacts of endemic area for tuberculosis Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009
Treatment of thymic carcinomas (TC): analysis of 9 cases Source: Eur Respir J 2005; 26: Suppl. 49, 540s Year: 2005
Multiple pulmonary nodules of the right middle lobe revealing the coexistence of 3 different types of benign lung tumours: a case report Source: Eur Respir J 2007; 30: Suppl. 51, 427s Year: 2007
Expression of claudins 1, 2, 3, 4, 5 and 7 in lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009
Is lung function diminished by 3 months of age in infants with cystic fibrosis (CF) diagnosed by newborn screening (NBS)? Source: Annual Congress 2010 - Functional assessment of paediatric lung disease Year: 2010
The tuberculosis of the pancreas. 2 cases reported Source: Annual Congress 2008 - Difficult tuberculosis cases Year: 2008